Infectious Disease Diagnostics Market


Infectious Disease

Diagnostics Market

Share, Global Trends,

Analysis, Research, Report,


Segmentation and Forecast,


Future Market Insights

Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting

services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,

technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.

We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.

Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and


We have a global presence with delivery centers across India specializing in providing global research reports and country

research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.

We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for

our client.

Research Capabilities

• Customized Research

• Syndicated Research

• Investment Research

• Social Media Research

Sector Coverage

• Automotive and Transportation

• Electronics, Semiconductor, and ICT

• Retail and Consumer Products

• Industrial Automation and Equipment

• Chemicals & Materials

• Food and Beverages

• Services and Utilities

• Energy, Mining, Oil, and Gas







Social Media


Subscription Information

For detailed subscription information please contact

Hari. T (Sr. Manager - Global Business Development)

T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268


Report Description

Infectious disease diagnostics is process of identifying the presence of foreign

antigen/organism with the help of various diagnostic tools. Infectious disease conditions

are highly prevalent in under developed regions due to lack of awareness for personal

hygiene, minimal healthcare expenditures and absence of efficient physician services.

The high incidence of infectious diseases across emerging economies formulate a major

share in overall market. This has grab the attention of in vitro diagnostic device

manufactures to invest into emerging economies. These companies are taking efforts to

develop and commercialize cost effective tools for the infectious disease diagnosis.

Presently, the gold standard tests available for bacterial infections and sexually

transmitted disease diagnosis have major market share. However, these test are expected

to replace by molecular techniques in future.

Infectious Disease Diagnostics Market: Drivers and Restraints

Increasing incidence of infectious disease, growing adoption of advanced molecular

techniques, and increasing interventions from government and non-profile organization

to reduce infectious disease in underdeveloped regions are endorsing the growth of

infectious disease diagnosis market. In addition, the companies operating in the disease

diagnostic technologies are focusing on the development of novel diagnostics, which

eventually provides pace to the market growth. However, lack of awareness for novel

diagnostic solution, absence of compiled regulatory guidelines and lower positivity rates

due to inferior laboratory conditions would hinder the growth of infectious disease

diagnostics market.

Report Description

Browse Full Report@

Infectious Disease Diagnostics Market: Segmentation

The global infectious disease diagnostics market is segmented based on, test type,

techniques, application, and end users.

Based on test type, the global infectious disease diagnostics market is segmented into the


Laboratory tests

Imaging test


Based on techniques, the global infectious disease diagnostics market is segmented into

the following:

Conventional techniques

Biochemical techniques

Molecular techniques

Request For TOC@

Report Description

Based on condition, the global infectious disease diagnostics market is segmented into

the following:

Bacterial Infection

Viral Infection

CNS infections

Cardiovascular infection

Fungal infection

GI infections

Sexually transmitted disease


Based on end use, the global infectious disease diagnostics market is segmented into the


Diagnostic laboratories

Academic and medical institutes

Contract Research Organization

Hospitals and Surgical centers

Report Description

Infectious Disease Diagnostics Market: Overview

By test type, the laboratory tests hold prominent share owing to its lower cost and easy

availability. The emerging economies are the prime contributors of laboratory test

segment especially in Asia-Pacific region, owing to high positivity rates. Laboratory test

are first line of diagnostics referred by physicians which includes, blood test, urine test,

spinal tap, throat swabs, and stool test. By techniques, the molecular diagnostic

techniques such as PCR, and other nucleic acid amplification test would gain prominence

in developed region. Based on condition, the bacterial infections, GI infections and

Sexually transmitted disease have the largest share in infectious disease testing market,

owing to high prevalence especially in emerging economies.

Request Free Report Sample@

Infectious Disease Diagnostics Market: Region-wise Outlook

Emerging economies such as India and China are the primary consumer for infection

disease testing market, owing to growing urbanization which leads to unhygienic

environment in the cities. Countries belongs to Asia-Pacific and Africa regions have

largest share in infectious disease diagnosis market due to high prevalence and incidence

of infectious diseases especially sexually transmitted disease and bacterial infections.

North America and European countries will ahead towards the adoption on high end

infectious disease diagnostic with the help of molecular technologies. This increasing

adoption of premium diagnostic techniques would sustain the market share of infectious

Report Description

Infectious Disease Diagnostics Market: Key Players

Key companies operational in infectious diseases testing market are Becton Dickinson &

Company, Cepheid Inc., Abbott Laboratories, BioMerieux, Hologic Inc., Bio-Rad

Laboratories Inc., Danaher Corporation, Affymetrix, Alere Inc., and DiaSorin. These

companies are majorly focusing on getting approval for the commercialiation of their

novel product launch. Recently, in 2015, Bio-Rad Laboratories, Inc. has got approval from

US FDA for its BioPlex 2200 HIV Ag-Ab assay, which is used for HIV antigens and HIV


Thank You!

To know more about us, please visit our website:

For sales queries or new topics email us on:

For other queries contact: Mr. Sudip Saha

Future Market Insights: 616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989, United States

T: +1-347-918-3531 | D: +1-845-579-5705

More magazines by this user
Similar magazines